Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01911104 · ClinicalTrials.gov registry record · NA
Exercise Resistance in Type 2 Diabetes
A NA study of Type 2 Diabetes, sponsored by AdventHealth Translational Research Institute.
- Active
- Registry status
- NA
- Development phase
- 84
- Enrollment target
- 1
- Study location
NCT01911104 is a NA study of Type 2 Diabetes that is active but no longer recruiting, run by AdventHealth Translational Research Institute. The registered enrollment target is 84 participants, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01911104, a NA study of Type 2 Diabetes, is active but no longer recruiting, sponsored by AdventHealth Translational Research Institute.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 84 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to collect data to help researchers identify factors that prevent certain individuals from receiving the beneficial effects of exercise.
Conditions Studied
Interventions
- BEHAVIORAL Exercise
Study Locations (1)
Florida
- Translational Research Institute for Metabolism and Diabetes - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2013-10-31 |
| Est. Completion | 2025-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01911104
The ClinicalTrials.gov registry entry for NCT01911104 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (92% lower). The listed sponsor is AdventHealth Translational Research Institute, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Type 2 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Exercise is the first listed.
NCT01911104 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT01911104 about?
NCT01911104 is a clinical study titled "Exercise Resistance in Type 2 Diabetes". The purpose of this study is to collect data to help researchers identify factors that prevent certain individuals from receiving the beneficial effects of exercise.
What is the current status of trial NCT01911104?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 84 participants. The study started on 2013-10-31. Estimated completion is 2025-06.
What conditions does trial NCT01911104 study?
This clinical trial studies the following conditions: Type 2 Diabetes.
What interventions are being tested in trial NCT01911104?
The interventions under investigation include: Exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT01911104?
This trial is sponsored by AdventHealth Translational Research Institute, which has 54 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01911104 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Enhancing Telemedicine for T2D
RECRUITING · NA
-
Sleep and Glycemic Control in Type 2 Diabetes Adolescents
RECRUITING · NA
-
Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients
RECRUITING · NA
-
Ultrasound Effects on Glycemic Control in T2DM
RECRUITING · NA
-
A Randomized Double-Blinded and Placebo-Controlled Trial to Assess the Efficacy of Biophoton Therapy to Treat Type 2 Diabetes
RECRUITING · NA
-
High Fructose Diet, the Gut Microbiome, and Metabolic Health
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.